We are live on
!
Find out more
Handelsbanken Fonder Portfolio holdings
AUM
$35.1B
1-Year Est. Return
47.76%
This Fund
S&P 500
This Quarter
Est. Return
-12.61%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$15.4B
AUM Growth
-$2.54B
(-14%)
Cap. Flow
+$226M
Cap. Flow
% of AUM
1.47%
Top 10 Holdings %
Top 10 Hldgs %
22.5%
Holding
1,736
New
36
Increased
439
Reduced
483
Closed
127
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$46.8M |
| 2 |
Apple
AAPL
|
+$42.3M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$38.2M |
| 4 |
Sunrun
RUN
|
+$27.6M |
| 5 |
SolarEdge
SEDG
|
+$27.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$307M |
| 2 |
Darling Ingredients
DAR
|
+$63.2M |
| 3 |
LHCG
LHC Group LLC
LHCG
|
+$45M |
| 4 |
Teradyne
TER
|
+$29.2M |
| 5 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$27.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.92% |
| 2 | Healthcare | 21.91% |
| 3 | Consumer Discretionary | 11.44% |
| 4 | Financials | 11.29% |
| 5 | Industrials | 9.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1426
Axsome Therapeutics
AXSM
$11.2B
| $249K | ﹤0.01% |
6,500
-1,000
| -13% | -$31.6K |
|
|
AXNX
1427
DELISTED
Axonics, Inc. Common Stock
AXNX
| $249K | ﹤0.01% |
4,400
-3,400
| -44% | -$186K |
|
1428
National Vision
EYE
$1.51B
| $248K | ﹤0.01% |
9,000
| – | – |
|
1429
Knowles
KN
$3.23B
| $248K | ﹤0.01% |
14,290
-7,900
| -36% | -$148K |
|
1430
Matsons
MATX
$6.39B
| $248K | ﹤0.01% |
3,400
-1,900
| -36% | -$163K |
|
1431
Globalstar
GSAT
$10.7B
| $247K | ﹤0.01% |
13,413
| – | – |
|
1432
Matthews International
MATW
$722M
| $247K | ﹤0.01% |
8,630
-1,900
| -18% | -$58.1K |
|
1433
American Eagle Outfitters
AEO
$2.73B
| $244K | ﹤0.01% |
21,792
| – | – |
|
1434
Federal Signal
FSS
$7.51B
| $244K | ﹤0.01% |
6,860
-8,500
| -55% | -$292K |
|
1435
Strategy Inc
MSTR
$38.2B
| $244K | ﹤0.01% |
14,860
+4,000
| +37% | +$116K |
|
1436
PAR Technology
PAR
$770M
| $244K | ﹤0.01% |
6,500
| – | – |
|
1437
Patrick Industries
PATK
$2.78B
| $244K | ﹤0.01% |
7,062
| – | – |
|
|
PRO
1438
DELISTED
PROS Holdings
PRO
| $244K | ﹤0.01% |
9,300
| – | – |
|
1439
Dillards
DDS
$9.59B
| $243K | ﹤0.01% |
1,100
-900
| -45% | -$260K |
|
|
RTL
1440
DELISTED
The Necessity Retail REIT, Inc. Class A Common Stock
RTL
| $243K | ﹤0.01% |
33,352
-7,000
| -17% | -$52.7K |
|
1441
Addus HomeCare
ADUS
$2.2B
| $240K | ﹤0.01% |
2,883
-800
| -22% | -$67.1K |
|
1442
Celldex Therapeutics
CLDX
$3.35B
| $240K | ﹤0.01% |
8,900
| – | – |
|
1443
Shift4
FOUR
$3.79B
| $238K | ﹤0.01% |
7,200
| – | – |
|
1444
CoreCivic
CXW
$3.13B
| $237K | ﹤0.01% |
21,300
-2,600
| -11% | -$31.4K |
|
1445
Gibraltar Industries
ROCK
$1.45B
| $237K | ﹤0.01% |
6,109
| – | – |
|
1446
AppFolio
APPF
$7.22B
| $236K | ﹤0.01% |
2,600
| – | – |
|
|
PGTI
1447
DELISTED
PGT, Inc.
PGTI
| $235K | ﹤0.01% |
14,100
-3,200
| -18% | -$57.6K |
|
1448
Live Oak Bancshares
LOB
$2.01B
| $234K | ﹤0.01% |
6,900
| – | – |
|
|
THS
1449
DELISTED
Treehouse Foods
THS
| $230K | ﹤0.01% |
5,509
-2,400
| -30% | -$88.1K |
|
|
CERE
1450
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $230K | ﹤0.01% |
8,700
-1,600
| -16% | -$45.4K |
|
Similar funds
GAM
Handelsbanken Fonder's Q2 2022 Portfolio in Review
As of Q2 2022, Handelsbanken Fonder held 1,736 positions worth $15.4B, down 14% from $17.9B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Handelsbanken Fonder's Q2 2022 filing shows 36 new, 439 increased, 483 reduced and 127 closed positions. Its largest new stake was Avantor: 226,479 shares worth $7.04M. The largest sale was Amazon, an estimated $307M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Handelsbanken Fonder's largest Q2 2022 buy was Avantor: 226,479 shares worth $7.04M.
- Handelsbanken Fonder added most to NVIDIA in Q2 2022, an estimated $46.8M increase.
- Handelsbanken Fonder's biggest Q2 2022 reduction was Amazon, cutting an estimated $307M.
- Handelsbanken Fonder fully exited Cerence in Q2 2022, selling an estimated $12.9M.
- Handelsbanken Fonder's ten largest holdings make up 22% of its $15.4B portfolio in Q2 2022.
- Handelsbanken Fonder opened 36 new positions and closed 127 in Q2 2022.
- Handelsbanken Fonder's portfolio value fell 14% quarter-over-quarter to $15.4B.
Based on Handelsbanken Fonder's 13F filing for Q2 2022, filed 3 Aug 2022.